Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Philip Scheltens

Showing results (421-430 of 903) with videos related to

Pageof 91
Sort By:
Biological Psychiatry|August 14, 2022
Overlap of Neuroanatomical Involvement in Frontotemporal Dementia and Primary Psychiatric Disorders: A Meta-analysisHulya Ulugut, Calvin Trieu, Colin Groot, et al.
JAMA Neurology|October 20, 2017
Interpreting Biomarker Results in Individual Patients With Mild Cognitive Impairment in the Alzheimer's Biomarkers in Daily Practice (ABIDE) ProjectIngrid S van Maurik, Marissa D Zwan, Betty M Tijms, et al.
Alzheimer'S Research & Therapy|August 11, 2017
On the path to 2025: understanding the Alzheimer's disease continuumPaul S Aisen, Jeffrey Cummings, Clifford R Jack, et al.
The American Journal of Geriatric Psychiatry : Official Journal of the American Association for Geriatric Psychiatry|April 10, 2013
White matter hyperintensities and cognitive impairment during electroconvulsive therapy in severely depressed elderly patientsMardien L Oudega, Eric van Exel, Mike P Wattjes, et al.
Journal of Alzheimer'S Disease : JAD|September 10, 2014
Angiotensin-converting enzyme in cerebrospinal fluid and risk of brain atrophyHadassa M Jochemsen, Wiesje M van der Flier, Emma L Ashby, et al.
Alzheimer'S Research & Therapy|November 28, 2013
The S-Connect study: results from a randomized, controlled trial of Souvenaid in mild-to-moderate Alzheimer's diseaseRaj C Shah, Patrick J Kamphuis, Sue Leurgans, et al.
Neurology|December 21, 2012
Differential effect of APOE genotype on amyloid load and glucose metabolism in AD dementiaRik Ossenkoppele, Wiesje M van der Flier, Marissa D Zwan, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|August 20, 2009
Relationship of cerebrospinal fluid markers to 11C-PiB and 18F-FDDNP bindingNelleke Tolboom, Wiesje M van der Flier, Maqsood Yaqub, et al.
Neurology|September 3, 2013
Progression to dementia in memory clinic patients without dementia: a latent profile analysisSebastian Köhler, Renske Hamel, Nicole Sistermans, et al.
Plos One|February 4, 2012
Does a family meetings intervention prevent depression and anxiety in family caregivers of dementia patients? A randomized trialKarlijn J Joling, Harm W J van Marwijk, Filip Smit, et al.
Pageof 91

Showing results (421-430 of 903) with videos related to

Sort By:
Pageof 91
Biological Psychiatry|August 14, 2022
Overlap of Neuroanatomical Involvement in Frontotemporal Dementia and Primary Psychiatric Disorders: A Meta-analysisHulya Ulugut, Calvin Trieu, Colin Groot, et al.
JAMA Neurology|October 20, 2017
Interpreting Biomarker Results in Individual Patients With Mild Cognitive Impairment in the Alzheimer's Biomarkers in Daily Practice (ABIDE) ProjectIngrid S van Maurik, Marissa D Zwan, Betty M Tijms, et al.
Alzheimer'S Research & Therapy|August 11, 2017
On the path to 2025: understanding the Alzheimer's disease continuumPaul S Aisen, Jeffrey Cummings, Clifford R Jack, et al.
The American Journal of Geriatric Psychiatry : Official Journal of the American Association for Geriatric Psychiatry|April 10, 2013
White matter hyperintensities and cognitive impairment during electroconvulsive therapy in severely depressed elderly patientsMardien L Oudega, Eric van Exel, Mike P Wattjes, et al.
Journal of Alzheimer'S Disease : JAD|September 10, 2014
Angiotensin-converting enzyme in cerebrospinal fluid and risk of brain atrophyHadassa M Jochemsen, Wiesje M van der Flier, Emma L Ashby, et al.
Alzheimer'S Research & Therapy|November 28, 2013
The S-Connect study: results from a randomized, controlled trial of Souvenaid in mild-to-moderate Alzheimer's diseaseRaj C Shah, Patrick J Kamphuis, Sue Leurgans, et al.
Neurology|December 21, 2012
Differential effect of APOE genotype on amyloid load and glucose metabolism in AD dementiaRik Ossenkoppele, Wiesje M van der Flier, Marissa D Zwan, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|August 20, 2009
Relationship of cerebrospinal fluid markers to 11C-PiB and 18F-FDDNP bindingNelleke Tolboom, Wiesje M van der Flier, Maqsood Yaqub, et al.
Neurology|September 3, 2013
Progression to dementia in memory clinic patients without dementia: a latent profile analysisSebastian Köhler, Renske Hamel, Nicole Sistermans, et al.
Plos One|February 4, 2012
Does a family meetings intervention prevent depression and anxiety in family caregivers of dementia patients? A randomized trialKarlijn J Joling, Harm W J van Marwijk, Filip Smit, et al.
Pageof 91